Acyclovir and post-herpetic neuralgia

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6985.1005 (Published 15 April 1995) Cite this as: BMJ 1995;310:1005

Two other participating study centres report different results

  1. M W Mckendrick,
  2. M J Wood
  1. Consultant physician Department of Infectious Diseases and Medicine, Royal Hallamshire Hospital, Sheffield S10 2JF
  2. Consultant physician Department of Infection and Tropical Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS

    EDITOR,—J I McGill and J E White report follow up data1 on 57 of 74 patients from Southampton originally treated as part of a three centre study of acyclovir versus placebo in herpes zoster in elderly patients.2 3 The original protocol required patients (mean age 71.7 years) to be followed up for six months or until pain free for one month. We are not clear about some of McGill and White's data. They state that 10 (37%) of the placebo group had …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription